HomeAbout

TL;DR CNBC


Pharma giant Sanofi opens $595 million vaccine facility in Singapore to prepare for potential pandemics - TL;DR CNBC

Pharma giant Sanofi opens $595 million vaccine facility in Singapore to prepare for potential pandemics

Publishing timestamp: 2024-11-27 06:39:29


Summary

Sanofi opens an evolutive vaccine facility in Singapore, part of a 900 million euro investment to develop two new EVFs globally over five years. The facility, known as Modulus, can switch between making different vaccines or treatments in a matter of days and will contribute about 200 skilled jobs to Singapore. The facility aims to significantly bolster pandemic preparedness and response.


Sentiment: POSITIVE

Tickers: SAN-FRPFE

Keywords: francepfizer incsanofi sapharmaceuticalssingaporebusiness newsbiotechnology

Source: https://www.cnbc.com/2024/11/27/sanofi-opens-advanced-vaccine-facility-in-singapore-.html


Developed by Leo Phan